A First-in-human Study of YN001 in Healthy Volunteers

NCT05635084 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: YN001
DRUG: Placebo for YN001

Sponsor

Beijing Inno Medicine Co., Ltd.